| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | +Options Exercise | $1,837,309 | +14,467 | +9.43% | $127.00 | 167,889 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$1,837,379 | -12,596 | -7.5% | $145.87 | 155,293 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$107,360 | -736 | -0.47% | $145.87 | 154,557 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | +Options Exercise | $462,329 | +6,157 | +3.98% | $75.09 | 160,714 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$462,408 | -3,170 | -1.97% | $145.87 | 157,544 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$171,543 | -1,176 | -0.75% | $145.87 | 156,368 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | +Options Exercise | $225,763 | +6,030 | +3.86% | $37.44 | 162,398 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$225,902 | -1,546 | -0.95% | $146.12 | 160,852 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$257,756 | -1,764 | -1.1% | $146.12 | 159,088 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Sell | -$350,593 | -2,400 | -1.51% | $146.08 | 156,688 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Sell | -$2,922 | -20 | -0.01% | $146.08 | 156,668 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Sell | -$29,217 | -200 | -0.13% | $146.09 | 156,468 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Sell | -$14,609 | -100 | -0.06% | $146.09 | 156,368 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | +Options Exercise | $493,232 | +6,029 | +3.86% | $81.81 | 162,397 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$493,332 | -3,382 | -2.08% | $145.87 | 159,015 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$151,997 | -1,042 | -0.66% | $145.87 | 157,973 | Nov 7, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -14,467 | -100% | $0.00 | 0 | Nov 7, 2022 | Common Stock | 14,467 | $127.00 | Direct | F1 |
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -6,157 | -100% | $0.00 | 0 | Nov 7, 2022 | Common Stock | 6,157 | $75.09 | Direct | F2 |
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -6,030 | -49.92% | $0.00 | 6,049 | Nov 7, 2022 | Common Stock | 6,030 | $37.44 | Direct | F3 |
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -6,029 | -33.29% | $0.00 | 12,079 | Nov 7, 2022 | Common Stock | 6,029 | $81.81 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 27, 2018 date of grant. The SARs granted became fully exercisable on September 27, 2021. This exercise did not involve any open-market sale of the Issuer's Common Stock. |
| F2 | The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock. |
| F3 | The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. |
| F4 | The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock. |